Integra LifeSciences | IART - Trade Debtors


Integra LifeSciences reported $284.51M in Trade Debtors for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 3.67B
Cash and Equivalent USD 217.91M
Cost of Sales USD 206.27M
Current Assets USD 1.14B
Current Liabilities USD 929.81M
Debt USD 2.01B
EBIT USD -509.91M
EBITDA USD -472.22M
Employees 4.4K
EPS Earnings Per Share USD 0.45
Equity Capital and Reserves USD 1.04B
Gross Profit on Sales USD 209.33M
Interest Expense on Debt USD 21.04M
Interest Income USD 4.71M
Loan Capital USD 1.23B
Market Capitalization USD 1.25B
Net Income USD -484.07M
Operating Expenses USD 416.91M
Operating Profit USD -1.31M
Ordinary Share Capital USD 77.92M
PE Price to Earnings USD 63.02
Pre-Tax Profit USD -530.95M
Sales Revenues USD 415.6M
Selling and Administration Expenses USD 179.89M
Stock USD 465.13M
Trade Creditors USD 92.84M
Trade Debtors USD 284.51M

Trade Debtors Change Date
Abbott USD 10.23B 562M Jun/2025
AtriCure USD 66M 2.68M Jun/2025
Baxter International USD 1.65B 84M Mar/2025
Becton, Dickinson and Co. USD 2.94B 86M Jun/2025
Boston Scientific USD 2.69B 135M Mar/2025
CONMED USD 234.15M 13.01M Jun/2025
Cooper Companies USD 792.3M 11.4M Jul/2025
Dexcom USD 1.38B 207.1M Jun/2025
Edwards Lifesciences USD 751.9M 24.5M Mar/2025
Globus Medical USD 660.12M 122.01M Jun/2025
Hologic USD 609.3M 35.1M Jun/2025
Insulet USD 444.4M 42.1M Jun/2025
Integra LifeSciences USD 284.51M 32.06M Jun/2025
Intuitive Surgical USD 1.27B 47.7M Jun/2025
J&J USD 16.02B 1.18B Mar/2025
Medtronic USD 6.52B 400M Apr/2025
Merit Medical Systems USD 224.24M 7.49M Jun/2025
Smith & Nephew USD 1.48B 69M Jun/2025
Stryker USD 3.92B 43M Jun/2025
Tandem Diabetes Care USD 128.44M 1.88M Jun/2025
Teleflex USD 513.81M 49.29M Jun/2025
Zimmer Biomet Holdings USD 1.61B 77.9M Jun/2025